Skip to main content
. 2009 Apr 27;53(7):3024–3029. doi: 10.1128/AAC.01346-08

FIG. 2.

FIG. 2.

In vitro killing curves for orbifloxacin against E. coli (A), S. aureus (B), S. intermedius (C), and P. mirabilis (D) clinical isolates. Numerical values on the right for each panel are orbifloxacin concentrations (μg/ml).